Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients.
Jie LiAn K LeKevin T ChaungLinda HenryJoseph K HoangRamsey CheungMindie H NguyenPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Concomitant NAFLD had no impact on the long-term rates of CVS and/or BR in treated CHB patients.